M. Miles Braun
University of Connecticut(US)
Publications by Year
Research Areas
Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, Pneumonia and Respiratory Infections, Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical studies and practices
Most-Cited Works
- → Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent(2001)3,683 cited
- → Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration(2002)661 cited
- → Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist(2003)458 cited
- → Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept(2002)448 cited
- Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.(2003)
- → Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents(2003)387 cited
- → Understanding vaccine safety information from the Vaccine Adverse Event Reporting System(2004)379 cited
- → Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases(2005)355 cited
- → Risk of Anaphylaxis After Vaccination of Children and Adolescents(2003)321 cited
- → Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor(2004)303 cited